首页> 外国专利> Composition for treating liver diseases comprising a Hsp90 inhibitor and Method for screening an agent for treating liver diseases through inhibition of Hsp90 and Core protein interaction

Composition for treating liver diseases comprising a Hsp90 inhibitor and Method for screening an agent for treating liver diseases through inhibition of Hsp90 and Core protein interaction

机译:包含Hsp90抑制剂的治疗肝病的组合物和通过抑制Hsp90和核心蛋白相互作用筛选治疗肝病的药物的方法

摘要

PURPOSE: A therapeutic agent containing Hsp90 inhibitors for treating liver diseases is provided to effectively treat liver diseases. CONSTITUTION: A composition for treating liver diseases caused by a hepatitis virus infection containing a Hsp90 inhibitor as an active ingredient. The Hsp90 inhibitor contains low molecular compounds, antibodies, antisense oligonucleotide, siRNA, shRNA, miRNA, and polypeptides. A method for screening materials for treating liver diseases comprises: a step of providing Hsp90 and HBV core proteins; a step of contacting a test material with proteins; and a step of detecting interaction between Hsp90 and HBV core proteins.
机译:目的:提供一种含有Hsp90抑制剂的治疗肝病的治疗剂,以有效治疗肝病。组成:用于治疗由肝炎病毒感染引起的肝脏疾病的组合物,包含Hsp90抑制剂作为有效成分。 Hsp90抑制剂包含低分子化合物,抗体,反义寡核苷酸,siRNA,shRNA,miRNA和多肽。筛选用于治疗肝病的材料的方法包括:提供Hsp90和HBV核心蛋白的步骤;使测试材料与蛋白质接触的步骤;以及检测Hsp90与HBV核心蛋白之间相互作用的步骤。

著录项

  • 公开/公告号KR101221777B1

    专利类型

  • 公开/公告日2013-01-11

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20110006882

  • 发明设计人 정구흥;심희연;

    申请日2011-01-24

  • 分类号A61K39/395;A61K38/16;A61P31/12;A61P31;

  • 国家 KR

  • 入库时间 2022-08-21 16:25:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号